REQUEST A DEMO
Total
USD $0.00
Search more companies

Clinica Versalles Ips S.A.S (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: All Other Professional, Scientific, and Technical Services | Management of Companies and Enterprises | Other Ambulatory Health Care Services
Full name: Clinica Versalles Ips S.A.S Profile Updated: January 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Clinica Versalles Ips S.A.S is based in Colombia. The head office is in Saravena. It operates in the Ambulatory Health Care Services industry. The enterprise was incorporated on May 22, 2015. The company’s latest financial report indicates a net sales revenue increase of 18.83% in 2025. There was a total growth of 44.63% in Clinica Versalles Ips S.A.S’s total assets over the same period. The net profit margin of Clinica Versalles Ips S.A.S increased by 0.76% in 2025.

Headquarters
Cl 30 # 25 - 116
Saravena; Arauca;

Contact Details: Purchase the Clinica Versalles Ips S.A.S report to view the information.

Basic Information
Registered Capital:
Purchase the Clinica Versalles Ips S.A.S report to view the information.
Financial Auditors:
Purchase the Clinica Versalles Ips S.A.S report to view the information.
Incorporation Date:
May 22, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Clinica Versalles Ips S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
18.83%
Total Operating Revenue
18.83%
Operating Profit
36.36%
EBITDA
52.32%
Net Profit/Loss for the Period
33.43%
Total Assets
44.63%
Total Equity
23.47%
Operating Profit Margin
1.59%
Net Profit Margin
0.76%
Return on Equity (ROE)
1.78%
Debt / Equity
0.45%
Quick Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?